🇩🇪 Pf-04171327 in Germany

Pf-04171327 (pf-04171327) regulatory status in Germany.

Marketing authorisation

BfArM

  • Status: approved

Pf-04171327 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Pf-04171327 approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Pf-04171327 in Germany?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.